Pipeline

Vaccine targeting Interleukin 17

Indication Preclinical Phase I Phase II Phase III
Psoriasis* Preclinical Phase I Phase II Phase III
Psoriasis arthritis Preclinical Phase I Phase II Phase III
Rheumatoid arthritis Preclinical Phase I Phase II Phase III

Vaccine targeting Interleukin 13

Indication Preclinical Phase I Phase II Phase III
Eczema Preclinical Phase I Phase II Phase III
Asthma Preclinical Phase I Phase II Phase III
  • * Regulatory approval to initiate clinical testing in place.